🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This mechanistic study is designed to investigate the effect of vildaglipti...
Status
Completed
Location
Novartis
Start Date
2006-09
Trial ID
NCT00390520
Treatments Being Tested
The purpose of this study was to determine whether the initiation of a vild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03-30
Trial ID
NCT01528254
Treatments Being Tested
This study is not being conducted in the United States. Vildagliptin is an ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-06
Trial ID
NCT00351832
Treatments Being Tested
The present study is a phase I, single-centre, double-blind, randomized, cr...
Status
Completed
Location
Diabeteszentrum Bad Lauterberg
Start Date
2011-11
Trial ID
NCT02749032
Treatments Being Tested
This mechanistic study will evaluate the effect of vildagliptin on glucose-...
Status
Completed
Location
Diabetes Zentrum Bad Lauterberg
Start Date
2006-10
Trial ID
NCT00396071
Treatments Being Tested
Vildagliptin, an antidiabetic drug that inhibits the dipeptidyl peptidase- ...
Status
Withdrawn
Location
Faculty of Medicine
Start Date
2020-05-01
Trial ID
NCT04410341
Treatments Being Tested
The purpose of this study is to determine whether monotherapy with Vildagli...
Status
Completed
Location
Medical University of Vienna
Start Date
2009-09
Trial ID
NCT00980356
Treatments Being Tested
This is a 2-3 period parallel group study with an adaptive element in Type ...
Status
Completed
Location
Advanced Clinical Research
Start Date
2008-11
Trial ID
NCT00821977
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of vild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04
Trial ID
NCT01357252
Treatments Being Tested
Many people with type 2 diabetes cannot maintain target blood glucose level...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2004-05
Trial ID
NCT00099944
Treatments Being Tested